Market Place
Sourcing Support
Invagen Pharms`s Generics Linagliptin Receives Approval in US
03 Sep 2024 //
FDA
Cipla unit recalls anti-seizure drug because of faulty packaging
12 Dec 2023 //
FIERCE PHARMA
InvaGen Issues Voluntary Nationwide Recall of Vigabatrin for Oral Solution
09 Dec 2023 //
PR NEWSWIRE
InvaGen`s Generic Vilazodone Hydrochloride Receives Approval in the U.S.
06 Dec 2022 //
FDA
Enforcement Report - Week of December 15, 2021
15 Dec 2021 //
FDA
Ascent Pharms Inc`s Generic Gabapentin Receives Approval in the US
01 Oct 2021 //
FDA
Ascent Pharms`s Generic Topiramate Receives Approval in the US
26 Aug 2021 //
FDA
Invagen Pharms` Generic Penicillamine Receives Approval in US
19 Aug 2021 //
FDA
InvaGen `s Generic Vilazodone Hydrochloride Receives Approval in US
10 Apr 2021 //
FDA
Ascent Pharms`s Generic Venlafaxine Hydrochloride Receives Approval In US
26 Oct 2020 //
FDA
Drugmakers struggle to meet demand for antidepressant Zoloft amid COVID-19
03 Jun 2020 //
FIERCE PHARMA
Enforcement Report - Week of May 27, 2020
27 May 2020 //
FDA
InvaGen Pharmaceuticals`s Generic Vigabatrin Receives Approval in US
03 Dec 2019 //
FDA
FDA to Withdraw Generic Drug
26 Oct 2019 //
RAPS
FDA greenlights nine Lyrica generics
25 Jul 2019 //
IN-PHARMATECHNOLOGIST
Invagen Pharms Generic Pregabalin Receives Approval In US
23 Jul 2019 //
FDA
Lyrica generics roll: Pfizer blockbuster finally hits patent cliff
23 Jul 2019 //
FIERCE PHARMA
InvaGen Pharma gets USFDA approval for neuropathic pain management drug
22 Jul 2019 //
BUSINESS STANDARD
FDA Approves First Lyrica Generics From 9 Sponsors
22 Jul 2019 //
RAPS
Dr Reddy`s Laboratories, Cipla arm recall drugs from American market
29 Apr 2019 //
BUSINESS-STANDARD
Enforcement Report - Week of April 24, 2019
24 Apr 2019 //
FDA
Ascent Pharms Generic Omega-3-acid Ethyl Esters Receives Approval In US
01 Mar 2019 //
FDA
Invagen Pharm`s Generic Lurasidone Hydrochloride Receives Approval in US
03 Jan 2019 //
FDA
Enforcement Report - Week of October 17, 2018
17 Oct 2018 //
FDA
Enforcement Report - Week of September 26, 2018
26 Sep 2018 //
FDA
Enforcement Report - Week of April 18, 2018
18 Apr 2018 //
FDA
Enforcement Report - Week of April 11, 2018
11 Apr 2018 //
FDA
Latuda® (Lurasidone HCl): Sumitomo Dainippon Pharma v. Invagen Pharmaceuticals
08 Mar 2018 //
PATENT LITIGATION
Invagen Pharm’s Generics Sevelamer Carbonate Receives Approval In US
30 Oct 2017 //
FDA
Invagen Pharm’s Generic Bupropion Hydrochloride Receives Approval In US
21 Sep 2017 //
FDA
InvaGen Infringed Diabetes Drug Patent, Pharma Cos. Say
24 Aug 2017 //
LAW360
Invagen Pharms Generic Clindamycin Palmitate HCL Receives Approval In US
08 May 2017 //
FDA
Eliquis (Apixaban): Bristol-Myers Squibb & Pfizer v. InvaGen Pharmaceuticals
05 Apr 2017 //
PATENT LITIGATION
Invagen Pharms Generic Fenofibrate Receives Approval In US
28 Mar 2017 //
FDA
Invagen`s Generic Atorvastatin Calcium Receives Approval In US
09 Jan 2017 //
FDA
Invagen`s Generic Lurasidone Hydrochloride Receives Tentative Approval In US
02 Dec 2016 //
FDA
Ascent`s Generic Dutasteride Received Approval In US
22 Oct 2016 //
FDA
Piramal Bulks up in Injectable Generics, Buying Five Drugs from J&J
12 Oct 2016 //
FIERCE PHARMA
Invagen Pharms Generic Amlodipine Besylate; Valsartan Approved In US
16 Sep 2016 //
FDA
Cipla gets USFDA nod for generic anti-depressant drug
30 Aug 2016 //
ECONOMIC TIMES
Invagen Pharms ANDA Trospium Chloride Receives FDA Nod
24 Aug 2016 //
FDA
Street positive on Cipla despite weak results
16 Aug 2016 //
BUSINESS STANDARD
Invagen Pharm`s Generic Olanzapine approved in US for Schizophrenia
16 Mar 2016 //
FDA
Cipla completes $550 million acquisition of 2 US generic drug companies
18 Feb 2016 //
BUSINESS STANDARD
Over 200 drugs under development, top 50 with $30 billion potential: Cipla
13 Jan 2016 //
ET HEALTHWORLD
Cipla to acquire 100% of generic businesses in US for $550M
04 Sep 2015 //
PR NEWSWIRE
New York Set To Get Another Drug Manufacturing Project
17 Mar 2015 //
FIERCE PHARMA MANUFACTURING
